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Introduction
In bacteria, most secretory and membrane proteins are trans-
ported across or are integrated into the plasma membrane by a 
process  that  is  similar  to  protein  translocation  across  the  ER 
membrane in eukaryotes (Driessen and Nouwen, 2008; Park 
and Rapoport, 2012). The translocation of these proteins is 
triggered by hydrophobic sequences, either cleavable signal 
sequences or noncleaved transmembrane (TM) sequences. The 
polypeptide substrates are translocated across the membrane 
through a hydrophilic channel formed by a conserved heterotri-
meric membrane protein complex, the SecY complex in bacte-
ria and archaea, and the Sec61 complex in eukaryotes. The 
complex consists of a large -subunit (SecY or Sec61p) that 
spans the membrane ten times, and two smaller, single-spanning 
- and -subunits (called SecG and SecE in bacteria). The chan-
nel associates with different partners that provide the driving 
force for translocation. In bacteria, the SecY channel can either 
associate with the ribosome to translocate proteins during their 
synthesis (cotranslational translocation), or it can cooperate 
with the cytosolic ATPase SecA to transport proteins after 
completion of their synthesis (post-translational translocation). 
The exact mechanism of protein translocation is still poorly 
understood. In particular, it is unclear whether one or more 
SecY/Sec61 complexes are required for translocation, an issue 
that impacts on several crucial aspects of translocation.
The question of how many SecY/Sec61 copies form the 
translocation channel has been controversial. Based on crystal 
structures of SecY complexes from different bacterial and 
archaeal species, it was proposed that a single copy of the com-
plex forms the translocation channel (Van den Berg et al., 2004; 
Tsukazaki et al., 2008; Zimmer et al., 2008; Egea and Stroud, 
2010). The channel has an hourglass shape (Van den Berg et al., 
2004), with an empty cytoplasmic cavity and an extracellular 
cavity that is filled with a short helix, the plug, which moves out 
of the way during protein translocation. The constriction of the 
hourglass is formed by a pore ring of amino acids, which likely 
surround the polypeptide chain during its passage through the 
channel  (Van  den  Berg  et  al.,  2004).  Translocation  through   
a single SecY copy is supported by disulfide cross-linking 
experiments with a SecA-dependent translocation substrate, 
which indicate that both the signal sequence and the following 
polypeptide segment can be cross-linked to the same SecY 
molecule (Osborne and Rapoport, 2007). In addition, electron 
T
he transport of proteins across the plasma mem-
brane in bacteria requires a channel formed from 
the SecY complex, which cooperates with either a 
translating ribosome in cotranslational translocation or the 
SecA ATPase in post-translational translocation. Whether 
translocation requires oligomers of the SecY complex is an 
important but controversial issue: it determines channel 
size, how the permeation of small molecules is prevented, 
and  how  the  channel  interacts  with  the  ribosome  and 
SecA. Here, we probe in vivo the oligomeric state of SecY 
by cross-linking, using defined co- and post-translational 
translocation intermediates in intact Escherichia coli cells. 
We show that nontranslocating SecY associated transiently 
through different interaction surfaces with other SecY mole-
cules inside the membrane. These interactions were signifi-
cantly reduced when a translocating polypeptide inserted 
into the SecY channel co- or post-translationally. Mutations 
that abolish the interaction between SecY molecules still 
supported viability of E. coli. These results show that a sin-
gle SecY molecule is sufficient for protein translocation.
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molecule can be rescued for translocation by linking it cova-
lently with a wild-type SecY copy (Osborne and Rapoport, 
2007). Furthermore, liposomes containing a single SecY mole-
cule had a reduced translocation activity compared with vesicles 
containing dimeric SecY (Deville et al., 2011), and lipid nano-
discs containing only one SecY molecule did not stimulate 
ATPase activity of SecA, in contrast to nanodiscs containing 
two SecY copies (Dalal et al., 2012). The coexpression of two 
different mutant SecYs, each displaying a translocation defect, 
also resulted in increased translocation activity (Dalal et al., 
2012). On the other hand, a recent study using fluorescence-
correlation spectroscopy suggested that a single SecY complex 
molecule is sufficient for SecA-mediated translocation in vitro 
(Kedrov et al., 2011). However, these experiments were per-
formed at extremely low SecY concentrations, which favor the 
dissociation of oligomers, and they were complicated by the 
fact that SecY is reconstituted into proteoliposomes in both ori-
entations. Most importantly, they did not monitor directly the 
mobility of active SecY channels, as the translocation substrate 
was unlabeled. A major problem with all these studies is that 
they are performed at rather artificial conditions.
Here, we have tested whether SecY oligomers are required 
for protein translocation under physiological conditions. To this 
end, we have developed new methodology that allowed us to 
study defined translocation intermediates in intact E. coli cells. 
We use these methods to demonstrate that a single SecY molecule 
is sufficient for both co- and post-translational translocation.
Results
Interactions between resting SecY 
channels in the E. coli plasma membrane
We first investigated the oligomeric state of resting SecY 
channels by treating E. coli cells with the transcription in-
hibitor rifampicin, which leads to the depletion of translocating 
polypeptides. Single cysteines were introduced into periplasmic 
loops of SecY and a bismaleimide was added to intact cells to   
induce cross-links between two SecY molecules. The cysteines 
were placed in four of the five periplasmic loops of SecY on the 
periphery of the channel (Fig. 1 A). Cysteines at positions 297 
and 395 were incorporated as part of a small, flexible insert to   
increase their accessibility to the cross-linking reagent. The mu-
tants and a cysteine-lacking control SecY were expressed from a 
plasmid under the endogenous promoter and were functional, as 
they complemented a secY deletion (Fig. S1 A).
We first tested whether the introduced cysteines are acces-
sible to a modification reagent (biotin-PEG2-maleimide) that 
has about the same size as the bismaleimide cross-linker. After 
treatment, modified proteins were detected after incubation with 
streptavidin by a mobility shift in SDS-PAGE. Streptavidin 
(SA)-bound SecY bands were visible for all cysteines (Fig. 1 B). 
Next, we incubated cells with bismaleimide-PEG3 (BM-PEG3),   
a bi-functional cross-linker with an 17Å linker between the 
maleimide groups. The reaction was quenched and the samples 
were subjected to SDS-PAGE and blotting with SecY antibod-
ies. Efficient cross-linking between two SecYs was seen with 
Cys151 and Cys212 (Fig. 1 C). Cross-linking with Cys297 
microscopy structures show that a single copy of Sec61/SecY 
complex is bound to a ribosome, with the cytoplasmic funnel of 
the translocation channel located underneath the ribosome tunnel 
(Ménétret et al., 2007, 2008; Becker et al., 2009; Frauenfeld   
et al., 2011). Based on the crystal structures, it has been pro-
posed that the channel itself is responsible for maintaining the 
membrane barrier for small molecules (Van den Berg et al., 
2004). Indeed, recent experiments support the view that the 
resting channel is sealed by both the pore ring and the plug   
domain; during translocation, the pore ring forms a gasket-like 
seal around the polypeptide chain, which prevents the perme-
ation of small molecules (Park and Rapoport, 2011).
Other  experiments  suggest  that  the  channel  is  formed 
from oligomers of the SecY/Sec61 complex. For example, fluor-
escence-quenching  experiments  indicate  a  channel  diameter   
of 40–60Å in intact microsomal membranes (Hamman et al., 
1997), which is inconsistent with the pore being formed from 
just one copy of the Sec61 complex. It was argued that these   
experiments are more reliable than those performed in detergent   
or with reconstituted SecY molecules (Hamman et al., 1997; 
Lin et al., 2011). Because of the large pore size, it was proposed 
that the membrane barrier for small molecules is provided by 
BiP binding to the luminal end of the channel in the resting 
state, and by the translating ribosome binding to the cytoplas-
mic side of the channel during translocation (Hamman et al., 
1998). Oligomers of the SecY/Sec61 complex have also been 
detected in intact membranes by cross-linking (Kaufmann et al., 
1999;  Schaletzky  and  Rapoport,  2006),  fluorescence  energy 
transfer (Mori et al., 2003; Snapp et al., 2004), and freeze-fracture 
electron microscopy experiments (Scheuring et al., 2005). How-
ever, it is unclear how the SecY/Sec61 molecules are arranged 
in these oligomers. A two-dimensional structure of the E. coli 
SecY complex in a lipid bilayer and cross-linking data indicate 
that two SecY molecules can associate back-to-back, i.e., with 
the long TM segments of the SecE subunits facing each other 
(Kaufmann et al., 1999; Breyton et al., 2002; Deville et al., 
2011). Recent EM data show a synthetic signal peptide bound 
to only one of the two back-to-back–associated SecY molecules 
(Hizlan et al., 2012). Other orientations of the SecY molecules 
in the oligomers have also been suggested (Das and Oliver, 
2011; Dalal et al., 2012). The oligomers detected in membranes 
cannot be very stable, as detergent-solubilized SecY complexes 
tend to behave as monomers, except under gentle solubilization 
conditions (Bessonneau et al., 2002).
Even  if  a  single  SecY/Sec61  complex  is  sufficient  to 
form the pore of the channel, this does not necessarily mean 
that protein translocation can occur with just one copy. For 
example, it is conceivable that additional Sec61/SecY mole-
cules stabilize the ribosome-channel junction (Schaletzky and 
Rapoport, 2006; Gumbart et al., 2009), or that a second SecY 
molecule prevents the dissociation of SecA from the translocat-
ing SecY copy, thereby enhancing the processivity of SecA dur-
ing translocation of a polypeptide chain (Osborne and Rapoport, 
2007; Deville et al., 2011; Dalal et al., 2012). In fact, several 
results suggest that a dimer may be required for at least SecA-
dependent translocation. Using proteoliposomes with recon-
stituted SecY proteins, it was shown that a defective SecY 883 A single SecY complex suffices for translocation • Park and Rapoport
(Das and Oliver, 2011). A model of a front-to-front associated 
SecY dimer would indeed bring Cys151 of two SecYs close to 
one another (Fig. S1 C).
To provide further evidence for these two distinct inter-
action surfaces of SecY, we used disulfide bridge cross-linking. 
For the front-to-front interaction, we placed single cysteines at 
different positions in the loop between TM segments 3 and 4 and 
examined the formation of a disulfide-bridged dimer (Fig. 1 D). 
A cysteine placed at position 154 gave a prominent cross-link, even 
without addition of an oxidation reagent (Fig. 1 D). As expected, 
or 395 was significantly less efficient. Similar results were 
obtained when BM-PEG3 was added directly to the bacterial 
culture, rather than to bacteria resuspended in buffer (Fig. S1 B). 
Cross-linking between Cys212 residues might have been ex-
pected, as this residue is close to the interface of a previously 
observed back-to-back SecY dimer (Fig. 1 A; Breyton et al., 
2002). However, Cys151 is in the loop between TM segments 
3 and 4, which lies on the opposite side of SecY (the front; 
Fig. 1 A). This front-to-front interaction may correspond to a 
dimer suggested by SecA–SecY cross-linking experiments 
Figure 1.  SecY complexes interact in vivo through different surfaces. (A) View of Thermotoga maritima SecY complex from the periplasm. The N- and   
C-terminal halves of SecY are colored blue and red, respectively, SecG in green, and SecE in yellow. Balls in magenta indicate positions that were mutated 
in the E. coli protein to cysteines. Note that two cysteines are part of an inserted segment. (B) The accessibility of cysteine residues introduced into SecY 
was tested in intact E. coli by modification with biotin-PEG2-maleimide, followed by incubation with streptavidin (SA). The samples were analyzed by SDS-
PAGE and immunoblotting with SecY antibodies (anti-SecY). The two bands correspond to one or two SecY molecules bound to tetrameric streptavidin.   
(C) The interaction of SecYs with the indicated cysteines was tested by addition of bismaleimide-PEG3 (BM-PEG3) to resuspended intact E. coli cells, pretreated 
with rifampicin for 30 min. The samples were analyzed by SDS-PAGE and immunoblotting for SecY. SecY2, cross-linked SecY dimers. (D) The front-to-front 
interaction of SecYs with the indicated cysteines was tested by spontaneous disulfide bridge formation in vivo. Where indicated, the samples were treated 
with -mercaptoethanol (-ME). (E) Scheme of a SecY complex containing SecE, SecG, and SecY in a single polypeptide chain. The gray dotted segments 
are added linkers. Residue L106 at the back of SecE (see A) is indicated. (F) The back-to-back interaction of single-chain SecY complexes with a cysteine 
at position 106 of SecE was tested by disulfide bridge formation after addition of the oxidant CuPh3 to cell lysates. Controls were performed with protein 
lacking a cysteine and with -ME addition after cross-linking.JCB • VOLUME 198 • NUMBER 5 • 2012   884
at the C terminus causes the ribosome to arrest translation, with 
the nascent chain associated as peptidyl-tRNA (Nakatogawa 
and Ito, 2001). DsbA-SecM was synthesized from the inducible 
arabinose promoter in cells expressing SecY from a plasmid 
under its native promoter. Expression of SecY at the endoge-
nous level was achieved by changing the AUG translation initi-
ation codon to the less efficient GUG codon. Insertion of the 
nascent chain into the SecY channel was monitored by disulfide 
bridge formation between a cysteine in DsbA-SecM (position 
19, immediately following its signal sequence) and a cysteine   
in SecY (position 68). For these experiments we used a newly 
developed strain that lacks the chromosomal secY copy, whose 
presence leads to an underestimate of cross-linking efficiency to 
the nascent chain, as wild-type SecY lacks a cysteine at the ap-
propriate position. Upon addition of the oxidant CuPh3 to intact 
cells, 73% of SecY was cross-linked to the nascent chain, as 
determined from the decrease of noncross-linked SecY (Fig. 2 B, 
lane 4; quantitation was confirmed by loading different amounts 
in lanes 1–3). As expected, no cross-linking between SecY and 
DsbA-SecM was observed when CuPh3 was omitted (lane 3) or 
the intensity of the cross-linked product was greatly dimin-
ished upon addition of a reducing reagent (-mercaptoethanol; 
-ME). The spontaneous formation of a disulfide bridge sug-
gests that two SecYs must come close to one another through 
their front surfaces.
To test for disulfide bridge formation between the back 
surfaces of SecY complexes, we used a SecE mutant with a 
cysteine at position 106 (Kaufmann et al., 1999). To exclude 
cross-linking between free SecE(106C) molecules that are not 
part of the SecY complex (Kaufmann et al., 1999), we gener-
ated a fusion protein containing SecE(106C), SecG, and SecY 
in one polypeptide chain (Fig. 1 E); the C terminus of SecE was 
linked to the N terminus of SecG with a short linker, and the   
C terminus of SecG was connected to the N terminus of SecY 
through an additional, unrelated TM segment. This fusion pro-
tein (scSecEGY) was stable and complemented a secY-null 
mutant (Fig. S1 A). When cells were lysed and treated with the   
oxidation reagent copper phenanthroline (CuPh3), a prominent 
disulfide-linked dimer of the fusion protein was observed after 
blotting with antibodies to either SecY or the N-terminal His-tag 
(Fig. 1 F). No dimer was seen when the cysteine was lacking or 
when -ME was added after cross-linking. Thus, SecY com-
plexes can interact with each other through their back surfaces. 
When one cysteine was introduced at the front (position 151), 
and another one at the back (position 212), the addition of the 
bismaleimide cross-linker led to a ladder of cross-linked SecY 
products (Fig. S1 D), indicating that the two interaction sur-
faces in the SecY complex can be used at the same time.
To  test  the  stability  of  the  SecY  oligomers,  we  ex-
pressed simultaneously a SecY molecule with a cysteine at 
either position 151 or 212 from the endogenous promoter, 
and an additional SecY copy lacking a cysteine (SecY
Cys) from 
the inducible arabinose promoter; SecY
Cys also contained a   
C-terminal calmodulin-binding peptide (CBP) tag (SecY
Cys-CBP) 
to  distinguish  it  from  the  cysteine-containing  SecY  copy.   
If SecY forms stable oligomers, one would expect that the 
coexpression of the two SecY molecules over an extended 
time period (1 h) leads to defined assemblies that contain both 
cysteine-containing and -lacking SecY molecules, and the cross-
linking yield should therefore decrease. Upon expression of   
SecY
Cys-CBP, the ratio of cysteine-free to cysteine-containing 
SecY molecules reached 1.5:1, but the cross-linking efficiency 
of cysteine-containing SecY molecules was not reduced (Fig. S1,   
E and F). These data support the notion that the interactions   
between SecY molecules with both their front and back surfaces 
are relatively short-lived.
Translocation intermediates can be 
generated in vivo with just one SecY copy
Next, we tested whether the cotranslational insertion of a poly-
peptide into the translocation channel requires a SecY oligo-
mer. To this end, we generated a translocation intermediate   
in vivo, using a previously established substrate (DsbA-SecM, 
formerly called NC100; Park and Rapoport, 2011). This is a 
polypeptide of 100 amino acids, containing the signal sequence 
of DsbA (Fig. 2 A), which targets the substrate to the cotransla-
tional pathway (Schierle et al., 2003). A SecM-stalling sequence   
Figure 2.  Saturation of SecY channels with a cotranslational translocation 
intermediate. (A) Scheme of a cotranslational translocation intermediate 
generated with the substrate DsbA-SecM. The nascent chain contains the 
signal sequence of DsbA at the N terminus, a Myc-tag for detection, and 
a C-terminal SecM-stalling sequence. Its insertion into the SecY channel is 
monitored by disulfide bridge formation between cysteines in the nascent 
chain and SecY. (B) DsbA-SecM was expressed from the arabinose (Ara)-
inducible promoter in cells producing SecY at approximately endogenous 
level using a GUG translational start codon (plasmid pACYC-SecYEG). 
After addition of the oxidant CuPh3 to the cell culture to induce disulfide 
bridge formation, the lysate was analyzed by SDS-PAGE and blotting with 
SecY antibodies. Where indicated, rifampicin (Rif) was added for different 
time periods. Red arrows and black asterisks indicate cross-links between 
SecY and substrate or endogenous proteins, respectively. For quantification   
of three independent experiments, see Fig. 3 C, right panel.885 A single SecY complex suffices for translocation • Park and Rapoport
modified as demonstrated by blotting with HRP-conjugated 
streptavidin (Fig. 3 D, lane 3). The localization of the modi-
fied proteins in the cytosol was previously demonstrated by 
cell fractionation (Park and Rapoport, 2011). Most of the 
permeability is due to nontranslocating, resting channels, as 
the addition of rifampicin did not drastically change cyto-
solic protein modification (lane 4). When OmpA-GFP was 
expressed under the inducible arabinose promoter, the extent 
of modification was reduced to a level similar to that seen 
with cells expressing wild-type SecY (lane 2 vs. 10). Expres-
sion of a signal sequence mutant of OmpA-GFP did not have 
this effect (lane 8). Similar results were obtained when the per-
meation of chloride ions was tested after conversion of E. coli 
cells into spheroplasts (Fig. S3). Thus, most of the SecY chan-
nels can be occupied with the post-translational translocation 
substrate OmpA-GFP.
The oligomeric state of the SecY channel 
engaged in translocation
We next tested whether the insertion of a polypeptide into 
the SecY channel changes the oligomeric state of SecY. The 
cotranslational (DsbA-SecM) or post-translational (OmpA-
GFP) substrate was expressed under the arabinose promoter 
in cells expressing SecY with a single cysteine at either posi-
tion 151 (at the front) or 212 (at the back). Cross-linking with 
the  bi-functional  reagent  BM-PEG3  showed  that  both  the 
front-to-front and back-to-back interactions of SecY molecules 
were drastically reduced (Fig. 4, lane 4 vs. 2, lane 10 vs. 8, 
lane 16 vs. 14, and lane 22 vs. 20). Thus, it appears that SecY 
oligomers dissociate into monomers upon insertion of a trans-
locating polypeptide chain. Because both front-to-front and 
back-to-back dimers dissociate, it seems likely that SecY mole-
cules weakly associate with each other in the plane of the 
membrane, and that the equilibrium is shifted toward monomers 
upon insertion of a translocating polypeptide.
To investigate the possibility that a translocating SecY 
channel might associate with a nontranslocating SecY copy, we 
performed experiments under conditions where not all channels 
are occupied with a model substrate. We first tested whether   
a SecY channel containing the cotranslational substrate DsbA-
SecM can be cross-linked back-to-back with a nontranslocating 
SecY channel. These experiments used the single-chain scSec-
EGY construct with a cysteine at position 106 of SecE for back-
to-back cross-linking, and a cysteine at position 68 of SecY for 
cross-linking with the substrate. To achieve low occupancy of 
SecY with substrate, we reduced ribosome-associated nascent 
chains by expression of MazF, an RNase that cleaves mRNAs 
at ACA sequences (Zhang et al., 2003). The occupancy was 
indeed reduced (Fig. 5 A, lane 15). For the experiments, the 
cells were first treated with 5,5-dithiobis-(2-nitrobenzoic acid) 
(DTNB) to induce disulfide bridge formation between SecY 
and the substrate, and then cell extracts were treated with CuPh3 
to test for cross-linking between SecY molecules. Both cross-
links between SecY and DsbA-SecM (lanes 9 and 10, 19 and 20) 
and between SecY and SecY (lanes 18 and 20) were observed, 
but no double cross-links containing two SecYs and substrate 
(lanes 10 and 20). Assuming that substrate binding does not 
when the cells were treated with rifampicin to clear all trans-
location sites before addition of the oxidant (lanes 7–10). Also, 
this cross-linked product was not generated when DsbA-SecM   
expression remained uninduced, although minor cross-links to 
endogenous nascent chains were observed instead (lanes 5 and 6). 
The observed cross-linking yield of 73% is a lower estimate 
because some SecY channels may be occupied by endogenous 
substrates even after expression of DsbA-SecM, and disulfide 
formation is not 100% efficient. The fact that the cross-linking 
efficiency is substantially higher than 50% argues that only one 
molecule of SecY is required to accommodate the translocating 
DsbA-SecM chain.
To perform similar experiments with a post-translational 
substrate, we developed a new method to generate a transloca-
tion intermediate with a SecA-dependent substrate (OmpA-
GFP). This polypeptide contains 79 amino acids, including the 
signal sequence of the post-translational substrate proOmpA, 
fused to a fast-folding GFP variant (Pédelacq et al., 2006). With 
this substrate, one expects that the N terminus inserts into the 
SecY channel and that the folded GFP blocks further translo-
cation through SecA and SecY (Fig. 3 A). To monitor inser-
tion of the polypeptide into the channel, a cysteine was placed 
immediately after the signal sequence at position 21, and an-
other cysteine into SecY (position 68). Efficient disulfide cross-
linking between OmpA-GFP and SecY was observed upon 
addition of an oxidant to intact cells (Fig. 3 B, lane 2; the appear-
ance of two cross-linked bands is due to incomplete unfolding 
of GFP in SDS sample buffer). No cross-linking was seen when 
either the substrate or SecY lacked the cysteine (lanes 6 and 8), 
when the cysteines were modified with N-ethylmaleimide (NEM) 
before addition of the oxidant (lane 3), or when the signal se-
quence was rendered nonfunctional by introducing two argi-
nine residues (lane 10). As expected, the cross-linked product 
disappeared upon addition of the reducing agent -ME (lane 4). 
These data demonstrate that a stable, post-translational trans-
location intermediate can be generated in vivo. With this sub-
strate and SecY expressed at its endogenous level, 67% of 
all SecY molecules could be cross-linked (Fig. 3 C, lane 4; 
controls as in Fig. 2 B). When the cysteine was placed at posi-
tion 32 of OmpA-GFP, instead of position 21, the cross-linking 
efficiency was even higher (74%; see Fig. S2). Given that the 
cross-linking efficiency is substantially higher than 50%, only 
one molecule of SecY is required to accommodate the translo-
cating OmpA-GFP chain.
To further investigate whether the majority of translo-
cation sites are occupied with OmpA-GFP, we tested whether 
the polypeptide substrate can block the permeation of small 
molecules through an open SecY channel. We have previously 
shown that SecY lacking its plug domain (P) is permeable to 
various small molecules, including the modification reagent 
biotin-maleimide and chloride ions, and that a cotranslationally 
inserted polypeptide chain can block the permeation of these 
molecules (Park and Rapoport, 2011). We now asked whether 
the post-translationally inserted polypeptide OmpA-GFP can 
do the same. When biotin-maleimide (biotin-PEG2-maleimide) 
was added to cells expressing SecY(P), various cytosolic 
proteins, including a prominent protein of 30 kD (p30), were JCB • VOLUME 198 • NUMBER 5 • 2012   886
Figure 3.  Saturation of SecY channels with a post-translational translocation intermediate. (A) Scheme of a post-translational translocation intermediate 
generated with SecA and the substrate OmpA-GFP. The translocating chain contains the signal sequence of OmpA at the N terminus and the “superfolder” 
GFP at the C terminus. Its insertion into the SecY channel is monitored by disulfide bridge formation between cysteines in the substrate and SecY. (B) The 
insertion of OmpA-GFP, containing a cysteine at position 21 (21C), into SecY containing a cysteine at position 68 (68C) was tested by disulfide bridge 
formation after the addition of the oxidant CuPh3 to intact E. coli cells. Where indicated, the substrate or SecY lacked a cysteine or the cysteines were 
blocked with N-ethylmaleimide (NEM) before addition of CuPh3. As a control, a substrate was used with a defective signal sequence (RR-21C). Where 
indicated, disulfide bridges were reduced by -mercaptoethanol (-ME). All samples were analyzed by SDS-PAGE followed by blotting with SecY or GFP 
antibodies. (C) OmpA-GFP was expressed from the arabinose (Ara)-inducible promoter in cells producing SecY at approximately endogenous level using a 
GUG translational start codon (plasmid pACYC-SecYEG). After addition of CuPh3, the lysate was analyzed by SDS-PAGE and blotting with SecY antibodies. 
Where indicated, rifampicin (Rif) was added for different time periods. Red arrows and black asterisks indicate cross-links between SecY and substrate   
or endogenous proteins, respectively. The right panel shows quantification of the cross-linking efficiency between SecY and translocation substrates, based 
on the decrease of noncross-linked SecY in experiments such as shown in the left panel and Fig. 2 B. Three different experiments were analyzed (mean 887 A single SecY complex suffices for translocation • Park and Rapoport
originates from SecY complexes containing endogenous SecE. 
Indeed, when the same mutant was expressed in a strain lacking 
endogenous SecE, no dimer formation was observed (Fig. 6 B). 
Remarkably, this strain had no detectable growth defect (Fig. 6 C), 
suggesting that a back-to-back–associated SecY dimer is not 
required for protein translocation.
To disrupt the front-to-front association of SecY mole-
cules, we introduced arginine residues into TM segment 3 of 
SecY,  which  is  close  to  the  predicted  interaction  surface. 
Based on the crystal structure (Tsukazaki et al., 2008; Zimmer 
et al., 2008), we placed two arginines at positions where their 
side chains would point away from the SecY complex. To 
avoid problems with membrane integration efficiency, we also 
replaced some of the less hydrophobic amino acids in TM3 
with  more  hydrophobic  ones.  The  resulting  SecY  mutant 
(TM3
RR) was totally defective in front-to-front dimerization, 
as measured by cross-linking of SecY with a cysteine at po-
sition 151 after addition of BM-PEG3 (Fig. 6 D). However, 
when present as the sole copy, the mutant SecY supported cell 
growth indistinguishably from the wild-type strain (Fig. 6 E). 
Thus, a front-to-front–associated SecY dimer is also not es-
sential for protein translocation. A mutant of the SecY com-
plex that carried mutations disrupting both front-to-front and 
back-to-back associations (SecY(TM3
RR) and SecE(106R)) was 
also able to complement a strain lacking both SecE and SecY 
and grew with wild-type kinetics (Fig. S5). Thus, even the 
simultaneous disruption of both interactions has no deleterious 
effect on translocation.
One  potential  caveat  to  our  conclusion  is  that  a  small 
amount of dimers may still be formed in the mutants and might 
be essential for the viability of cells. To exclude this possibility, 
we expressed wild-type and mutant SecY at different levels and 
monitored both dimer formation and cell viability. To express 
SecY at reduced levels, we used plasmids with different origins 
drastically change the distance between the cysteines in the 
interacting SecY molecules, it appears that substrate does not 
insert into back-to-back–associated SecY dimers.
Next, we performed similar experiments with the post-
translational substrate OmpA-GFP. To increase the percentage 
of nonoccupied SecY channels, we reduced the expression of 
OmpA-GFP by changing the translation start codon from AUG 
to the less efficient GUG codon, and by adding rifampicin for 
30 min to clear the SecY channels from most endogenous sub-
strates (Fig. S4). As a result, the cross-linking efficiency of SecY 
to OmpA-GFP was drastically reduced (Fig. 5 B, lane 15). The 
cells were first treated with DTNB to induce SecY substrate 
cross-links, and then with CuPh3 to test for SecY–SecY back-to-
back cross-linking. While single cross-links were prominent (lanes 
9, 10, 19, and 20; and lanes 18, 20), double-cross-links containing 
both two SecYs and substrate were weak (lanes 10 and 20). Thus, 
it appears that the majority of substrate molecules insert into 
monomeric SecY.
Next,  we  tested  whether  front-to-front–associated  SecY 
molecules can insert a translocation substrate. Here, we exploited 
the fact that SecYs with a cysteine at position 154 spontane-
ously form a disulfide-bridged dimer. SecY also contained a 
cysteine at position 68 to test for the insertion of substrate 
containing a cysteine following the signal sequence. After in-
ducing the expression of either DsbA-SecM or OmpA-GFP, 
the oxidant CuPh3 was added to generate a disulfide bridge 
between SecY and substrate. With the cotranslational sub-
strate, efficient cross-links between SecY and SecY (Fig. 5 C, 
lanes 13–16) and between SecY and DsbA-SecM (lanes 4, 8, 12, 
and 16) were observed, but no double cross-links (lanes 8 and 16). 
Thus, the cotranslational substrate does not insert into front-
to-front–associated  SecY  dimers. With  the  post-translational 
substrate, weak double cross-links were seen (Fig. 5 D, lanes 8 
and 16), indicating that the majority of molecules also inserts 
into monomeric channels.
Dimerization-defective SecY mutants
To directly test the role of the back-to-back and front-to-front 
association of SecY molecules, we generated mutants in which 
these interactions are disrupted. We first screened for muta-
tions with defective back-to-back association by placing differ-
ent amino acids at position 106 of SecE, the point of closest 
contact of two SecY complexes. To this end, we expressed from 
a plasmid SecY complex containing mutant SecE and SecY 
with a cysteine at position 212; SecY dimer formation was de-
termined after addition of BM-PEG3. Placing a bulky or nega-
tively charged residue at position 106 of SecE reduced dimer 
formation only moderately, but introducing an arginine had a 
drastic effect, although the levels of SecE and SecY were only 
slightly reduced (Fig. 6 A). The residual dimer formation likely 
and SD). (D) OmpA-GFP with either a wild-type (WT) or defective (RR) signal sequence was expressed under the arabinose (Ara) promoter in cells produc-
ing wild-type SecY or SecY lacking its plug domain (P). Controls were performed with an empty vector (vec) and without Ara induction. Biotin-maleimide 
was added to the cells, and the modification of proteins was probed by SDS-PAGE and blotting with HRP-conjugated streptavidin. The samples were also 
probed with SecY, GFP, and trigger factor (TF; loading control) antibodies. Where indicated, cells were pretreated with rifampicin (Rif) before addition 
of biotin-maleimide. p30, a prominently modified cytosolic protein. The blue arrowheads indicate biotinylation of translocation-incompetent OmpA-GFP 
carrying a defective signal sequence.
 
Figure 4.  Dissociation of SecY oligomers upon insertion of a translocating 
chain. DsbA-SecM or OmpA-GFP was expressed from the arabinose (Ara)-
inducible promoter in cells producing SecY at approximately endogenous   
level using a GUG translational start codon. SecY carried either a cysteine 
at the front (SecY-151C) or at the back (SecY-212C). Cross-linking of   
SecYs (SecY2) was tested after addition of bismaleimide-PEG3 (BM-PEG3) 
to intact cells. Where indicated, cells were treated with rifampicin (Rif) 
before cross-linking.JCB • VOLUME 198 • NUMBER 5 • 2012   888
compromised in back-to-back dimer formation (Fig. 7 C, right). 
These data indicate that disruption of dimer formation has   
a negligible effect on cell growth, even when SecY levels are 
close to the minimum required for cell viability. Thus, a single 
copy of SecY is sufficient to support protein translocation.
Discussion
Our experiments provide strong evidence that a single SecY 
complex is sufficient for protein translocation in vivo. This 
implies that the pore of the translocation channel is formed 
from just one SecY molecule and that additional copies of 
SecY are not essential for moving a polypeptide co- or post-
translationally through the channel.
Our cross-linking experiments show that SecY complexes 
can associate with one another in the plane of the membrane 
by back-to-back and front-to-front associations. A back-to-back 
interaction of SecY molecules has been observed previously 
(Kaufmann et al., 1999; Breyton et al., 2002; Dalal et al., 2012), 
of replication and different translation start codons for the secY 
gene. With these constructs, the level of SecY expression could 
be  varied  from  127%  compared  with  the  endogenous  SecY 
level in wild-type cells all the way down to 5% (Fig. 7 A). As 
expected, lowering the SecY level decreased the cross-linking 
efficiency, both for the front-to-front and the back-to-back 
associations (Fig. 7 B). However, the decrease was less pro-
nounced than expected from a bimolecular cross-linking reac-
tion between randomly colliding SecY complexes, suggesting 
that the SecY–SecY interactions have a finite lifetime. When 
tested in a secY-null strain, the reduction of SecY levels to 
60% had no effect on growth (Fig. 7 C; left). A slight growth 
defect was seen at a level of 43% and a major defect at 23%. 
Importantly, the results were similar with a SecY mutant that   
is defective in front-to-front association (Fig. 7 C; middle). 
A slight difference in viability was seen at very low levels of SecY 
expression (25% of wild-type; Fig. 7 C), which is explained 
by the reduced stability of the SecY mutant (see immunoblots 
in Fig. 6 D). Similar results were obtained with a SecY complex 
Figure 5.  Preferential insertion of substrate into monomeric SecY complex. (A) A single-chain SecY complex with a cysteine at position 106 of SecE for 
back-to-back cross-linking was expressed under the endogenous promoter together with the cotranslational substrate DsbA-SecM under the arabinose (Ara) 
promoter. The level of DsbA-SecM was reduced by expression of the RNase MazF. Insertion of the nascent chain was monitored by disulfide bridge cross-
linking between DsbA-SecM and SecY after addition of DTNB to intact cells (first XL). After homogenization, a cell extract was treated with the oxidant 
CuPh3 to induce cross-links between SecY molecules (second XL). The samples were analyzed by SDS-PAGE and immunoblotting for Myc (substrate) and 
His (channel) tags. The red arrow indicates the position expected for double cross-links of SecY with SecY and DsbA-SecM. (B) As in A, but with the post-
translational substrate OmpA-GFP. The expression level of substrate was reduced by the use of a GUG translational start codon, and SecY channels were 
cleared of endogenous substrates by addition of rifampicin for 30 min. (C) SecY with a cysteine at position 154 for spontaneous front-to-front disulfide 
bridge formation was expressed together with DsbA-SecM. Channel insertion of DsbA-SecM was monitored by disulfide bridge formation between substrate 
and SecY after addition of CuPh3. Controls were performed with SecY lacking cysteines for SecY-SecY (154C) or SecY-substrate (68C) cross-linking. The 
red arrow indicates the position expected for double cross-links of SecY with SecY and DsbA-SecM. (D) As in C, but with OmpA-GFP. The cross-linking 
between substrate and position 154 of SecY (lane 6) might be explained by assuming that the proOmpA signal sequence is mobile (more so than that of 
DsbA), so that it comes close to position 154 at the lateral gate.889 A single SecY complex suffices for translocation • Park and Rapoport
are monomeric upon solubilization in detergent (Bessonneau 
et al., 2002).
Using new methods to assemble translocation intermedi-
ates in vivo, we show that short translocating polypeptides in-
sert into monomeric SecY. With an excess of substrate, almost 
all SecY complex molecules can be occupied with either a co- 
or post-translational translocation substrate. These experiments 
show that even if oligomers formed through interaction surfaces 
other than the front or back of the SecY complex, such oligo-
mers would not be required for the insertion of a translocation 
substrate into the channel. Polypeptide insertion occurs into mo-
nomeric SecY channels even under conditions where there are 
plenty of free SecY molecules available. In fact, for a cotransla-
tional substrate, both back-to-back and front-to-front dimers are 
entirely incompatible with translocation, as shown by the ab-
sence of dimer cross-links with SecY containing a translocating 
polypeptide. For a post-translational substrate, some molecules 
inserted into dimeric SecY, but most still preferred monomeric 
SecY. Taken together, these results indicate that the insertion of 
a polypeptide chain into the SecY channel requires only a single 
SecY copy. In principle, it is possible that later stages of translo-
cation require additional SecY copies. However, the fact that 
and a front-to-front association was suggested on the basis of 
SecA-SecY photo-cross-linking experiments (Das and Oliver, 
2011). Our results now show that, at least in the resting state, 
SecY molecules can interact with both surfaces inside the 
membrane of intact E. coli cells. In fact, it is possible that sur-
faces other than the front and back of a SecY complex can also 
mediate dimerization. Both the front-to-front and back-to-back 
interactions of SecY complexes appear to be transient, as dem-
onstrated by competition experiments with noncross-linkable 
SecY molecules. The interactions can be abolished by intro-
ducing positive charges into TM segments at the front or back 
of the SecY complex, likely because these charges lead to re-
pulsion of SecY complexes in the hydrophobic environment 
of the membrane. Taken together, our experiments argue against 
a defined oligomeric state of the SecY complex in native mem-
branes and suggest that SecY complexes interact relatively 
weakly inside the lipid bilayer, although the actual lifetime 
of the interactions remains to be determined. A weak inter-
action between SecY complexes is consistent with fluorescence-
correlation spectroscopy experiments, which show little dimer 
formation when SecY is present at low concentrations in lipo-
somes (Kedrov et al., 2011). It also explains why SecY complexes 
Figure 6.  Mutants disrupting the association of SecY complexes in the membrane. (A) The back-to-back association of SecY complexes was tested using 
a cysteine at position 212 and the bi-functional cross-linker bismaleimide-PEG3 (BM-PEG3). Mutations were introduced at position 106 of SecE to test their 
effect on SecY dimer (SecY2) formation. The samples were analyzed by SDS-PAGE and immunoblotting for SecY and His tag (SecE). The cross-linking 
efficiency was quantitated and is expressed relative to that with wild-type SecE. (B) As in A, but with the chromosomal SecE copy deleted. (C) The growth 
rate of the cells used in B was compared. The data shown are from a single representative experiment out of two repeats. (D) The front-to-front association 
of SecY complexes was tested using a cysteine at position 151 and the bi-functional cross-linker bismaleimide-PEG3 (BM-PEG3). Mutations were introduced 
in TM3 of SecY, as indicated (TM3
RR), to disrupt SecY dimer (SecY2) formation. Where indicated, cells were treated with rifampicin (Rif) before cross-linking. 
(E) The growth rate of the cells used in D was compared. The data shown are from a single representative experiment out of two repeats.JCB • VOLUME 198 • NUMBER 5 • 2012   890
a nontranslocating SecY copy with SecA. A similar interpre-
tation could apply to the observation that two defective SecY 
mutants can form an active complex (Dalal et al., 2012), that 
SecA has a substrate-stimulated ATPase activity only when 
interacting with two SecY molecules in lipid nanodiscs (Dalal 
et al., 2012), and that cross-linked SecY dimers have an increased 
translocation activity in single-molecule experiments (Deville 
et al., 2011). In all these cases, a nontranslocating SecY copy 
might boost the activity of the translocating SecY copy. However, 
our data indicate that these nontranslocating SecY copies are 
not essential for translocation.
The fact that cotranslational translocation requires only 
one SecY copy is consistent with mechanisms derived from 
electron microscopy data: the ribosome is bound to a single 
SecY mutants with disrupted back-to-back or front-to-front 
associations grew at the same rate as wild-type cells suggests 
that oligomers are not essential for the entire translocation pro-
cess. This conclusion is consistent with recent fluorescence-
correlation experiments (Kedrov et al., 2011).
Our results do not exclude the possibility that oligomer-
ization of SecY complexes may facilitate protein translocation. 
For example, a nontranslocating SecY molecule might contrib-
ute to SecA binding to the channel. Such an assumption could 
explain the previous observations that a defective SecY mutant 
can be rescued for translocation by its covalent association 
with a wild-type SecY copy (Osborne and Rapoport, 2007); 
a weakened interaction of the translocating SecY copy with 
SecA might be compensated for by additional interactions of 
Figure  7.  Oligomerization-defective  SecY 
mutants  have  a  negligible  growth  defect.  
(A) SecY was expressed at different levels by 
using plasmids with different origins of repli-
cation (approximate copy numbers: 10–12 for 
pACYC,  20–40  for  pRN1,  5  for  pSC101, 
and 1–2 for pBeloBAC) and different transla-
tion start codons for the secY gene (shown in   
brackets). Samples from equal numbers of cells 
were  analyzed  by  SDS-PAGE  and  immuno-
blotting with antibodies to the C terminus of SecY. 
In lanes 2–9, the endogenous SecY copy was   
tagged with CBP at the C terminus, which 
makes it nondetectable by SecY antibodies. The 
levels of SecY are given relative to that in wild-
type cells (lane 1). (B) SecY with a cysteine at 
position 151 (the front) or 212 (the back) was 
expressed at different levels from various plas-
mids. Cross-linking between SecYs was induced 
by  addition  of  bismaleimide-PEG3  (BM-PEG3) 
and the samples were analyzed by SDS-PAGE 
and  immunoblotting  with  SecY  antibodies.   
(C)  Wild-type  (WT)  SecY  complex  or  mutant 
complexes defective in either front-to-front asso-
ciation (SecY (TM3
RR)) or back-to-back associa-
tion (SecE(106R)) were expressed at different 
levels from various plasmids in a strain lacking 
endogenous SecY. The growth of colonies at 
37°C was analyzed at different time points after 
transformation. N.D., not determined.891 A single SecY complex suffices for translocation • Park and Rapoport
E. coli chromosomal secY- and secE-null strains were constructed   
by standard Red recombination techniques (Datsenko and Wanner, 2000).   
In brief, to make a secY-null strain (EP63), EP61 (rmf ompT; see Table S1) 
cells were transformed with Red recombinase–encoding pKD46 together 
with  pTet2-SecYEG,  which  expresses  the  wild-type  SecYEG  complex   
under a tetracycline-inducible promoter. The pTet2-SecYEG plasmid also 
includes the p15A origin of replication and a kanamycin resistance gene. 
After induction of Red recombinase, the cells were electroporated with 
a PCR product containing a hygromycin B resistance gene, flanked by 
short sequences homologous to the chromosomal secY locus (the PCR   
was performed using the forward primer 5-TCGAAGCTGCTGGCGG-
TAAAATCGAGGAATAAGTAGCAGATGGGTAAAAAGCCTGAACTC-3, 
the reverse primer 5-GAACTTTCATTTTTACTCTCCGTAACTTCTCGGGC-
GACCAATTATTCCTTTGCCCTCGGA-3; and pAG32 as a template). 
Colonies were selected on LB agar plates containing 50 µg/ml kanamycin, 
100 µg/ml hygromycin B, and 100 µg/ml anhydrotetracycline (aTet). 
Removal of the chromosomal secY gene was verified by PCR. The resulting 
strain cannot form a colony on plates without aTet, but grows normally 
when transformed by a plasmid constitutively expressing wild-type SecY 
(e.g., pACYC-SecYEG). To generate strains deleted in chromosomal secE 
(Fig. 6, B and C), EP52 (rmf ompT::kan secY-CBP::zeo) cells were trans-
formed with pKD46 and pACYC-SecYEG (containing either the wild-type 
or L106R mutant secE copy). Red recombinase–induced cells were electro-
porated with a PCR product containing a streptomycin resistance marker, 
flanked by short sequences homologous to the chromosomal secE locus 
(the PCR was performed using the forward primer 5-CGTTTCGATTTG-
GTTTGCCTCGCGATCGCGGGGTGAAAATGTTTGTAGAAAACTTCTGA-
CAGGTTGGTTTATGAGGGAAGCGGTGATCGC-3, the reverse primer 
5-CAAAACCGGAAAACGCCTGAACGACGTACCAGCGCTTTTTAGGA-
GCTTCAGACATATGAATATCCTCCTTATTTGCCGACTACCTTGGTG-3; 
and pCDFDuet-1 as a template). Selection was performed on plates con-
taining 40 µg/ml chloramphenicol and 30 µg/ml streptomycin. A secY/
secE-null strain (EP66) was constructed in essentially the same way, starting 
with the secY-null strain. The deletion of chromosomal secE was verified 
by PCR.
Growth of bacteria
Experiments  were  performed  with  the  following  strains:  EP62  (rmf 
ompT secY-CBP::zeo) for Figs. 1 (B and C), 6 (A and D), 7 (A and B), 
and S1 B; EP52 (rmf ompT::kan secY-CBP::zeo) for Fig. 3 D; EP53 
(rmf ompT secY-CBP::zeo glpF::kan) for Fig. S3; and EP63 (rmf 
ompT secY::hph) for Figs. 1 (D–F), 2 B, 3 (B and C), 4, 5, 6 E, 7 C, 
S1 (A, D–F), S2, and S4. To express SecY complexes, the cells were 
transformed with pACYC-SecYEG, which expresses all subunits of the 
SecY complex from a constitutive endogenous promoter (the rplN pro-
moter). When overexpression of a translocation substrate was needed, 
pBAD-NC100 (for DsbA-SecM) or pBAD-OmpA-GFP was additionally in-
troduced into the cells. When maximum occupancy of translocation sites 
by DsbA-SecM or OmpA-GFP was intended (Figs. 2 B, 3 [C and D], 4, 
S2, and S3), the GUG start codon was used for the SecY gene in pACYC-
SecYEG. For the competition experiments in Fig. S1 (E and F), the cells 
were cotransformed with pACYC-SecYEG containing the indicated SecY 
cysteine mutants and pBAD-SecY
CBPEG encoding cysteine-free SecY with a 
C-terminal calmodulin-binding peptide (CBP) tag. E. coli cells were picked 
from freshly transformed colonies, inoculated into LB medium supplemented 
with appropriate antibiotics (100 µg/ml ampicillin for pBAD and pRN1 plas-
mids; 40 µg/ml chloramphenicol for pACYC-SecYEG; and 15 µg/ml chlor-
amphenicol for pSC101 and pBeloBAC plasmids), and grown at 37°C to 
log phase (OD600nm = 0.4–0.6) before induction and any other manipu-
lations. To induce overexpression of DsbA-SecM and OmpA-GFP, 0.15% 
arabinose was added for 30 min at 37°C.
To monitor growth of E. coli cells producing a reduced level of the 
SecY complex (Fig. 7 C), competent EP63 cells were transformed with 50 ng 
of each SecY-expressing plasmid. Cells were first recovered at 37°C for 1 h 
in LB medium without antibiotics and plated on LB agar medium supple-
mented with appropriate antibiotics.
In vivo biotinylation and streptavidin gel-shifting assays
E. coli cultures were grown to log phase, and treated with 100 µg/ml rifam-
picin for 30 min. After harvesting 4 ml of each culture, the cells were resus-
pended in 1.5 ml of buffer containing 50 mM Tris-HCl, pH 7.5, 150 mM 
NaCl, and 1 mM EDTA. After addition of 0.4 mM biotin-PEG2-maleimide 
(Thermo Fisher Scientific), the suspension was incubated for 1 h at 4°C. After 
quenching with 20 mM -mercaptoethanol for 20 min at 4°C, the cells were 
washed three times with 1 mL of the buffer and then resuspended in 200 µl 
SecY channel in such a way that a nascent polypeptide can 
move directly from the ribosome tunnel into the SecY channel 
(Ménétret et al., 2007, 2008; Becker et al., 2009; Frauenfeld   
et al., 2011). Our new data, in conjunction with previous results 
(Park and Rapoport, 2011), also show that the pore residues of 
a single SecY molecule form a gasket-like seal that prevents the 
permeation of small molecules during co- and post-translational 
translocation. Given the structural conservation of the channel, 
it is likely that in eukaryotes the pore and membrane barrier are 
also formed from a single copy of the Sec61 complex.
For SecA-mediated translocation, the new results raise 
the interesting question of how an interaction of SecA with a 
single SecY molecule can push a polypeptide chain through the 
membrane. In one model, SecA would be processive, moving 
an entire polypeptide chain through the SecY channel without 
dissociating from it. The interaction of SecA with a single SecY 
molecule is in fact strong in the ATP-bound state, a state that 
could be visualized in a crystal structure of the complex (Zimmer 
et al., 2008). However, in the ADP-bound state, SecA has a 
weaker affinity for SecY (Zimmer et al., 2008), raising the pos-
sibility that SecA would dissociate if it did not have additional 
binding sites with the membrane. It had been assumed that these 
sites are provided by a nontranslocating SecY copy (Osborne 
and Rapoport, 2007), but it now appears that this mechanism is 
not essential.
A major aspect of the work presented here is the develop-
ment of methodology to generate protein translocation interme-
diates in vivo. All previous experiments on the mechanism of 
protein translocation had been done in vitro or had monitored 
in vivo heterogeneous populations of nascent chains. Our ability to 
generate both co- and post-translational translocation intermedi-
ates together with the structural information that is available for 
the SecY complex, SecA, and other translocation components, 
now opens a new era in the field in which detailed mechanistic 
questions can be asked in a physiological context.
Finally, it should be pointed out that the question addressed 
in this paper, i.e., the oligomeric state of the SecY complex, is 
relevant to other membrane proteins for which oligomerization   
is considered. For example, as in the case of SecY, it has been 
generally difficult to determine the oligomeric state of G protein–
coupled receptors or ion channels (Duffield et al., 2003; Hern 
et al., 2010; Grage et al., 2011; Kasai et al., 2011; Dixon et al., 
2012), and in several cases, it has been controversial whether 
oligomers are functionally important. Much of the uncertainty 
comes from the fact that membrane proteins often interact only 
weakly through hydrophobic surfaces inside the membrane. 
Thus, the in vivo cross-linking methodology and the manipula-
tion of interaction surfaces, developed by us for SecY, may help 
to test the role of oligomers in these cases as well.
Materials and methods
Bacterial strains and plasmids
Strains and plasmids used in this study are listed and described in Tables S1 
and S2. Standard PCRs and site-directed mutagenesis were performed 
with KOD polymerase (EMD Millipore) and were verified by sequencing. 
E. coli strain DH5 was used for all cloning procedures.JCB • VOLUME 198 • NUMBER 5 • 2012   892
SDS-PAGE, image acquisition, and densitometry analysis
SDS-PAGE was performed using 4–12% Bis-Tris gels (Invitrogen and Bio-
Rad Laboratories) with either MES-SDS or MOPS-SDS running buffer (Invit-
rogen).  For  each  SDS-PAGE  experiment,  samples  from  equal  numbers 
(OD600nm)  of  cells  were  loaded  on  lanes.  Rabbit  polyclonal  antibodies 
against the C terminus of E. coli SecY were described previously (Cannon 
et al., 2005). Mouse monoclonal antibodies recognizing an internal seg-
ment of E. coli SecY were a gift from Ian Collinson (University of Bristol, 
Bristol, England, UK). Mouse monoclonal anti-GFP (clones 7.1 and 13.1), 
anti-Myc (9E10), and anti-His antibodies (A00186) were obtained from 
Roche, Sigma-Aldrich, and Genscript, respectively. Rabbit polyclonal anti-
trigger factor (TF) antibodies (A01329) were obtained from Genscript. 
A standard ECL reagent was used to develop immunoblots. All images 
including immunoblots and agar plates were taken with the CCD-based 
device LAS-3000 (Fujifilm) using the acquisition software Image Reader 
LAS-3000 (Fujifilm). The levels of images were adjusted using Adobe 
Photoshop. ImageJ software (National Institutes of Health, Bethesda, MD) 
was used for densitometry analysis (using raw 16-bit images).
Online supplemental material
Fig. S1 shows the functionality of SecY mutants and the interaction between 
resting SecY complexes in vivo. Fig. S2 shows that the majority of SecY 
channels can be occupied with the OmpA-GFP substrate. Fig. S3 shows 
that insertion of OmpA-GFP reduces chloride permeation through the open 
SecY channel. Fig. S4 shows that the occupation of SecY with OmpA-GFP 
can be reduced by lowering the expression level. Fig. S5 demonstrates that 
a SecY mutant defective in both front-to-front and back-to-back dimerization 
is as functional as wild-type SecY. Tables S1 and S2 list the strains and 
plasmids used in this study. Online supplemental material is available at 
http://www.jcb.org/cgi/content/full/jcb.201205140/DC1.
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16 U/ml Benzonase nuclease (EMD Millipore), and 0.5% Triton X-100. 
25 µg streptavidin (Genscript) was added to a 40-µl aliquot of the reac-
tion, and binding was allowed for 1 h at 4°C. The samples were then 
supplemented with 0.1% SDS, 12.5% glycerol, and bromophenol blue 
for SDS-PAGE.
Cysteine cross-linking experiments
Cells were grown to log phase and pelleted by brief centrifugation. Where 
indicated, E. coli cultures were supplemented with 100 µg/ml rifampicin for 
30 min at 37°C before harvest. For cross-linking of SecY molecules with a 
bi-functional cross-linker, the cells were resuspended at the original volume 
in a buffer containing 50 mM Tris-HCl, pH 7.5, 150 mM NaCl, and 1 mM 
EDTA. Cross-linking was initiated by addition of 0.4 mM bismaleimide-PEG3 
(Thermo Fisher Scientific) and continued for 1 h at 4°C under gentle rocking. 
The reaction was stopped by addition of 30 mM -mercaptoethanol (incuba-
tion for 20 min at 4°C). The cells were collected and subjected to SDS-PAGE 
and immunoblotting. For Figs. 4, 6, 7 B, and S1 (B, E, and F), the cross-linking 
reactions were performed by directly adding 0.6 mM bismaleimide-PEG3 
to E. coli cultures in LB medium, without prior pelleting and resuspension. 
Relative SecY-SecY cross-linking efficiencies in Figs. 6 A and 7 B were calcu-
lated from the ratios of the band intensity of cross-linked and noncross-linked 
SecY (SecY2/SecY).
To  cross-link  single-chain  SecEGY  molecules  through  a  disulfide 
bridge, the cells were resuspended in 1/10 culture volume of buffer con-
taining 50 mM Tris-HCl, pH 7.5, and 300 mM NaCl, and homogenized 
by brief sonication. Cross-linking was performed by addition of 0.5 mM 
CuPh3 for 30 min at 23°C. The reaction was stopped by addition of 25 mM 
NEM and the samples were subjected to nonreducing SDS-PAGE. For 
reduction of the disulfide bridge, 2% -mercaptoethanol was added 
and the samples were incubated for 30 min at 50°C before SDS-PAGE.
For formation of a disulfide bridge between SecY and substrate, 
0.25 mM CuPh3 was directly added to a 1-mL aliquot of E. coli culture, fol-
lowed by gentle rocking for 10 min at 23°C. The reaction was quenched 
by addition of 20 mM NEM for 20 min at 4°C. The cells were pelleted and 
resuspended in SDS sample buffer for nonreducing SDS-PAGE.
Double disulfide-cross-linking of a substrate molecule and two single-
chain SecY molecules (Fig. 5, A and B) was performed as follows. For DsbA-
SecM, EP63 cells harboring pBAD(MazF)-NC100 and pACYC-scSecEGY 
were grown to mid-log phase. 0.15% arabinose was first added to the cul-
ture for 1 h to overproduce the nascent chains, and then 200 ng/ml aTet 
was added for the next 20 min to induce MazF expression. For OmpA-GFP, 
EP63  cells  harboring  pBAD-OmpA-GFP  (GUG)  and  pACYC-scSecEGY, 
0.15% arabinose was first added for 20 min to induce OmpA-GFP expres-
sion, followed by the addition of 100 µg/ml rifampicin for the next 30 min 
to block further synthesis of OmpA-GFP and endogenous proteins. Then, 
disulfide bridge formation between SecY and substrate was induced by 
addition of 1 mM DTNB in 25 mM Tris-HCl, pH 7.5, for 10 min at 23°C. 
The cells were transferred to 4°C, collected by centrifugation, and washed 
twice with buffer containing 50 mM Tris-OAc, pH 7.2, 20 mM Mg(OAc)2, 
and 100 mM NH4Cl before resuspension in 1/8 of culture volume. After 
breaking the cells by brief sonication, 0.5 mM CuPh3 was added to the 
lysate to induce disulfide cross-linking between single-chain SecEGY mole-
cules. After 15 min at 23°C, the reaction was stopped by addition of 
20 mM NEM. The samples were analyzed by nonreducing SDS-PAGE.
Measuring permeation of small molecules through the SecY channel
E. coli cells harboring pACYC-SecYEG (WT or P with a GUG-start   
codon) and pBAD-OmpA-GFP were grown in LB medium supplemented with 
50 µg/ml chloramphenicol and 100 µg/ml ampicillin to log phase. Expres-
sion of OmpA-GFP was induced by the addition of 0.15% arabinose for 
30 min at 37°C. Where indicated, 100 µg/ml rifampicin was added instead 
to the cultures for 30 min at 37°C. Permeation of biotin-PEG2-maleimide and 
of chloride ions were measured as described previously (Park and Rapoport, 
2011). In brief, to test permeation of biotin-PEG2-maleimide, 0.4 mM 
biotin-PEG2-maleimide (Thermo Fisher Scientific) was directly added to an 
aliquot of the culture at 23°C for 30 min. After quenching by addition of 
30 mM -mercaptoethanol, the cells were collected and subjected to SDS-
PAGE and blotting. To test permeation of chloride ions, cells were pelleted 
and resuspended in 20 mM Tris-HCl, pH 7.2, and 18% sucrose, and con-
verted into spheroplasts by addition of EDTA and lysozyme. The spheroplast 
suspension was rapidly mixed in a cuvette with a 19-fold volume of an iso-
osmotic solution of KCl (0.342 mol/kg) containing 10 µM valinomycin, 
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